Validation of the Dutch Translation of the Tobacco, Alcohol, Prescription Medication and Other Substances (TAPS)-Tool

NCT05273021 | Recruiting DMC

• 1 other identifier: ECSW-2021-051
• Study Type: observational
• Target: 150
• Locations: 1 country
• Sites: 3

Brief Summary

The aim of the study is to investigate the reliability and validity of the Dutch version of the TAPS-tool. This will be investigated in 2 groups: patients without intellectual disabilities treated in Flexible Assertive Community Treatment (FACT) teams and patients with intellectual disabilities. For the later group, an adjusted version of the TAPS-tool will be developed. For both groups the TAPS outcome will be compared to a golden standard.

Conditions

Substance Use; Severe Mental Disorder; Intellectual Disability, Mild

Keywords

TAPS; screener

Outcome Measures

Primary Outcomes (3)

• TAPS

  The TAPS-tool is a 2-phase screening instrument to detect substance use problems which can be used as an interview or as a self-administered questionnaire. TAPS 1 has a score from 0-4 (higher is more substance use). For a score of 1 or higher, TAPS 2 is also taken. TAPS 2 has a total score from 0-3 (higher is indication of more problematic use) for all of the 8 substances. Cut off score is +2.

  one assessment at the start of the treatment

• Measurement of Addiction for Triage and Evaluation (MATE)

  MATE is an instrument, developed in Europe to determine patient characteristics for the indication of care for people with addiction problems on a valid and reliable way. The MATE will be used for participants without intellectual disabilities. Modules 1, 4, and Q1 are used in this study. Module 1 (interview about substance use) for alcohol, nicotine, cannabis, opiates, cocaine, stimulant drugs, extacy, other drugs, sedative medicines and gambling. For every substance there is a cut off point for excessive use. There are no scores for module 1. Module 4: 11 binary questions (yes/no) about dependency and misuse of the problem area. The scoring range is 0 to 9 (cut off = 8). the higher the score, the worse the dependency. Module Q1: five questions about desire, based on a five point Likert-scale (score 0-4). Cut off = sum score \> 12. higher scores stand for more problematic desire.

  At the start of FACT treatment, only for participants of this study

• Substance use measurement for people with intellectual disabilities (SumID-Q)

  The SumID-Q is an extensive Dutch assessment instrument (interview) on substance use problems for people with intellectual disabilities. There are no total scores.

  Standard assessment at the start of the treatment, or when substance use problems are suspected

Secondary Outcomes (2)

• Health of the Nation Outcome Scales (HoNOS)

  Once at start of FACT treatment

• Manchester abbreviated quality of life measure (MANSA)

  Once, at start of FACT treatment

Study Arms (1)

participants with substance use problems

There are 2 subgroups: * Participants without intellectual disabilities * Participants with intellectual disabilities with and without severe mental illness

Diagnostic Test: TAPS

Interventions

TAPS DIAGNOSTIC_TEST

all participants are investigated by the Dutch TAPS tool (Tobacco, Alcohol, Prescription medication and other Substances-tool). A screener and short assessment of possible substance use problems

participants with substance use problems

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

secondary psychiatric care departments and special services for people with intellectual disabilities

You may qualify if:

• All patients treated in the participating FACT teams and for patients treated at the LVB-P (department for patients with intellectual disabilities and psychiatric disorders \[Dutch name\]) department of the GGZ Oost Brabant or the ORO foundation (ORO is no abbreviation but just a name of the institute).

You may not qualify if:

• If patients do not have sufficient command of the Dutch language or cannot concentrate for 20 minutes, the instruments are not taken

Sponsors & Collaborators

• Birgit Seelen-de Lang: lead
• Ggz Oost Brabant: collaborator

Study Sites (3)

GGZ Oost Brabant - FACT

Boekel, North Brabant, 5427 ZG, Netherlands

RECRUITING

GGZ Oost Brabant - LVB-P

Boekel, North Brabant, 5427 ZG, Netherlands

RECRUITING

Stichting ORO

Helmond, North Brabant, 5709 HL, Netherlands

RECRUITING

MeSH Terms

Conditions

Substance-Related Disorders; Mental Disorders; Intellectual Disability; Lymphoma, Follicular

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Neurodevelopmental Disorders; Lymphoma, Non-Hodgkin; Lymphoma; Neoplasms by Histologic Type; Neoplasms; Lymphoproliferative Disorders; Lymphatic Diseases; Hemic and Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases

Central Study Contacts

Birgit Seelen, MSc

CONTACT

0031 681405847; birgit.seelen-delang2@ru.nl

Cor de Jong, Dr

CONTACT

nispa.dejong@gmail.com

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Psychologist

Study Record Dates

• First Submitted: February 11, 2022
• First Posted: March 10, 2022
• Study Start: July 1, 2021
• Primary Completion: December 31, 2024
• Study Completion: July 1, 2025
• Last Updated: March 28, 2024

Record last verified: 2024-03

Data Sharing

• IPD Sharing: Will not share

Locations

NL (3)